-

Auna Announces Pricing of Initial Public Offering of US$360 Million (Gross Proceeds) of Class A Shares

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna”) a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced that it has priced its initial public offering of 30,000,000 class A ordinary shares (“class A shares”), at a price of US$12.00 per class A share.

Auna intends to use the net proceeds from the offering to repurchase 21.2% interest in Auna Salud S.A.C., as well as for other general corporate purposes, as described in its registration statement on Form F-1. To the extent the underwriters’ option to purchase additional shares described below is exercised in full, Auna will use those additional net proceeds to repay indebtedness under Auna’s Term Loans and certain working capital facilities.

The class A shares have been approved for listing on the New York Stock Exchange and will start trading on March 22, 2024 under the ticker symbol “AUNA”. The offering is expected to settle on or about March 26, 2024, subject to customary closing conditions. In connection with the offering, Auna has granted to the underwriters a 30-day option to purchase up to an additional 4,500,000 class A shares at the initial public offering price.

The offering is being made through an underwriting group led by Morgan Stanley, J.P. Morgan, BTG Pactual and Santander who are acting as global coordinators and joint bookrunners, and Citigroup and HSBC who are acting as joint bookrunners.

A registration statement on Form F-1 relating to these securities has been filed with, and declared effective by, the U.S. Securities and Exchange Commission (“SEC”). Copies of the registration statement can be accessed through the SEC’s website at www.sec.gov.

This press release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. Copies of the prospectus, when available, may be obtained by contacting: Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, J.P. Morgan Securities LLC, Attn: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at +1 (866) 803-9204 or by email at prospectus-eq_fi@jpmchase.com, Banco BTG Pactual S.A.—Cayman Branch, Attn: Prospectus Department, 601 Lexington Avenue, New York, New York 10282, by telephone at +1 (212) 293-4600, or by email at OL-BTGPactual-ProspectusDepartment@btgpactual.com, Santander US Capital Markets LLC, 437 Madison Avenue, 9th floor, New York, NY 10022, or by email at SanCapSyndicate@santander.us, Citigroup, Attn: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at +1 (800) 831-9146, or HSBC Securities (USA) Inc., 66 Hudson Boulevard East, New York, NY 10001, or by email at ny.equity.syndicate@us.hsbc.com.

About Auna

Auna operates hospitals and clinics in Mexico, Peru and Colombia and provides prepaid healthcare plans in Peru. As of December 31, 2023, Auna’s network included 31 healthcare network facilities, consisting of hospitals, outpatient, prevention and wellness facilities in Mexico, Peru and Colombia with a total of 2,308 beds.

 

Contacts

Investor Contact:
46A, Avenue J.F. Kennedy, Luxembourg
L- 1 855 Luxembourg
R.C.S. B267590

Investor Relations
contact@aunainvestors.com

Auna S.A.

NYSE:AUNA

Release Versions

Contacts

Investor Contact:
46A, Avenue J.F. Kennedy, Luxembourg
L- 1 855 Luxembourg
R.C.S. B267590

Investor Relations
contact@aunainvestors.com

More News From Auna S.A.

Auna Announces 4Q24 and FY 2024 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 (“fourth quarter 2024” or “4Q24”) and full year ended 2024 (“full-year 2024” or “FY24”). Financial results are expressed in Peruvian Soles (“S/” or PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unles...

Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey

MONTERREY, Mexico--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna’s commitment to becoming the leading oncolo...

Auna Announces Reporting Dates for Fourth Quarter and Full-Year 2024 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2024 financial results. Earnings Release Monday, March 10, 2025 Time: After Market Close Conference Call Tuesday, March 11, 2025 Time: 8:00 a.m. ET Quiet Period Monday, February 17 through Monday, March 10, 2025 To participate, please dia...
Back to Newsroom